Aligos Therapeutics Stock Probability of Future Stock Price Finishing Over 7.27
| ALGS Stock | USD 22.99 1.64 7.68% |
Aligos |
Aligos Therapeutics Target Price Odds to finish over 7.27
The tendency of Aligos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 7.27 in 90 days |
| 22.99 | 90 days | 7.27 | about 84.08 |
Based on a normal probability distribution, the odds of Aligos Therapeutics to stay above $ 7.27 in 90 days from now is about 84.08 (This Aligos Therapeutics probability density function shows the probability of Aligos Stock to fall within a particular range of prices over 90 days) . Probability of Aligos Therapeutics price to stay between $ 7.27 and its current price of $22.99 at the end of the 90-day period is about 83.34 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.34 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aligos Therapeutics will likely underperform. Moreover Aligos Therapeutics has an alpha of 1.2939, implying that it can generate a 1.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Aligos Therapeutics Price Density |
| Price |
Predictive Modules for Aligos Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aligos Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Aligos Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Aligos Therapeutics is not an exception. The market had few large corrections towards the Aligos Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aligos Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aligos Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.29 | |
β | Beta against Dow Jones | 1.34 | |
σ | Overall volatility | 4.58 | |
Ir | Information ratio | 0.12 |
Aligos Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aligos Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aligos Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aligos Therapeutics is way too risky over 90 days horizon | |
| Aligos Therapeutics appears to be risky and price may revert if volatility continues | |
| Aligos Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 15.53 M. Net Loss for the year was (87.68 M) with loss before overhead, payroll, taxes, and interest of (71.17 M). | |
| Aligos Therapeutics currently holds about 159.34 M in cash with (79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72. | |
| Aligos Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Can Aligos Therapeutics Afford To Invest In Growth |
Aligos Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aligos Stock often depends not only on the future outlook of the current and potential Aligos Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aligos Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.9 M | |
| Cash And Short Term Investments | 135.7 M |
Aligos Therapeutics Technical Analysis
Aligos Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Aligos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aligos Therapeutics. In general, you should focus on analyzing Aligos Stock price patterns and their correlations with different microeconomic environments and drivers.
Aligos Therapeutics Predictive Forecast Models
Aligos Therapeutics' time-series forecasting models is one of many Aligos Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aligos Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Aligos Therapeutics
Checking the ongoing alerts about Aligos Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aligos Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Aligos Therapeutics is way too risky over 90 days horizon | |
| Aligos Therapeutics appears to be risky and price may revert if volatility continues | |
| Aligos Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 15.53 M. Net Loss for the year was (87.68 M) with loss before overhead, payroll, taxes, and interest of (71.17 M). | |
| Aligos Therapeutics currently holds about 159.34 M in cash with (79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72. | |
| Aligos Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Can Aligos Therapeutics Afford To Invest In Growth |
Additional Tools for Aligos Stock Analysis
When running Aligos Therapeutics' price analysis, check to measure Aligos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos Therapeutics is operating at the current time. Most of Aligos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aligos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos Therapeutics' price. Additionally, you may evaluate how the addition of Aligos Therapeutics to your portfolios can decrease your overall portfolio volatility.